Q2 numbers overall better than expected...
Q2 numbers were better than we expected, with revenues of DKK 351m coming in 5% above ABGSCe, corresponding to +47% y-o-y growth (+3% adjusted for SDR). EBIT of DKK 41m came in above our estimate of DKK 30m, driven by stronger-than-expected performances in FK and SDR. Q2 also saw a DKK 141m gain on the securities portfolio (vs. our DKK 135m estimate), once again thanks to Novo Nordisk and NVIDIA.
LÄS MER